Skip to main content

Table 4 Clinical and pathological TNM stage

From: Feasibility research of enhanced recovery after surgery implemented in esophageal cancer patients who underwent neoadjuvant chemotherapy

Stage

NACT (n=52)

Non-NACT (n=271)

P

c TNM stage

    

<.001**

 

I

0 (0)

I

60 (22.1)

 
 

II

11 (21.2)

II

148 (54.5)

 
 

III

28 (53.8)

III‡

52 (19.2)

 
 

IVa

13 (25.0)

IVa‡

11 (4.1)

 

p TNM stage

ypTNM

 

pTNM

  
 

I

18 (34.6)

Tis

3 (1.1)

 
 

II

20 (38.5)

Ia

20 (7.4)

 
 

IIIa

3 (5.8)

Ib

30 (11.1)

 
 

IIIb

7 (13.5)

IIa

33 (12.2)

 
 

IVa

4 (7.7)

IIb

73 (26.9.)

 
   

IIIa

45 (16.6)

 
   

IIIb

55 (20.3)

 
   

IVa

12 (4.4)

 
  1. c TNM clinical TNM, NACT neoadjuvant chemotherapy, p TNM pathological TNM
  2. Numbers in parentheses are the percentages. Patient refused neoadjuvant chemotherapy
  3. P < 0.01